Pharmidex (United Kingdom)

Recent papers from Pharmidex (United Kingdom)

1. Development of a novel analytical pipeline to characterize morphological and molecular features of blood vessels within marginal regions of glioblastomaNeuro-Oncology Advances · 2026
2. Magnetic field-induced drug delivery from magnetic microporous nanocomposites through magnetic nanoparticles heating or motionMaterials & Design · 2026
3. P02.24.a Molecular and Morphological Features of Blood Vessels in Tumour Margin Regions of Glioblastoma Are Distinct From Tumour Core and Normal Brain, and Drug Delivery Is ReducedNeuro-Oncology · 2025
4. Biomass-Derived Nanoporous Carbon Honeycomb Monoliths for Environmental Lipopolysaccharide Adsorption from Aqueous MediaInternational Journal of Molecular Sciences · 2025
5. Combinatorial Therapy: Targeting CD133+ Glioma Stem-like Cells with a Polysaccharide–Prodrug Complex Functionalised Gold NanocagesBiomedicines · 2024
6. Pan-antiviral effects of a PIKfyve inhibitor on respiratory virus infection in human nasal epithelium and miceAntimicrobial Agents and Chemotherapy · 2023
7. Pan-antiviral effects of a PIKfyve inhibitor on respiratory virus infection in human nasal epithelium and mice2023
8. In situ gelation of thiolated poly(aspartic acid) derivatives through oxidant-free disulfide formation for ophthalmic drug deliveryColloids and Surfaces B Biointerfaces · 2023
9. Influence of Co-morbidities During SARS-CoV-2 Infection in an Indian PopulationFrontiers in Medicine · 2022
10. Human pharmacokinetics of XBD173 and etifoxine distinguish their potential for pharmacodynamic effects mediated by translocator proteinBritish Journal of Clinical Pharmacology · 2022
11. Can we Succeed in the Fight Against SARS-CoV-2 with its Emerging New Variants?Current Pharmaceutical Design · 2022
12. Activated Carbon/Pectin Composite Enterosorbent for Human Protection from Intoxication with Xenobiotics Pb(II) and Sodium DiclofenacMolecules · 2022
13. The World Against Versatile SARS-Cov-2 Nanomachines: Mythological or Reality?Current Stem Cell Research & Therapy · 2021
14. Relationship between anti-fungal effects and lung exposure of PC945, a novel inhaled antifungal agent, in Aspergillus fumigatus infected miceEuropean Journal of Pharmaceutical Sciences · 2021
15. Side group ratio as a novel means to tune the hydrolytic degradation of thiolated and disulfide cross-linked polyaspartamidesPolymer Degradation and Stability · 2021
16. Film-Forming Systems for the Delivery of DNDI-0690 to Treat Cutaneous LeishmaniasisPharmaceutics · 2021
17. Orally Administered Activated Charcoal as a Medical Countermeasure for Acute Radiation Syndrome in RatsApplied Sciences · 2021
18. The role of nanotechnology in current COVID-19 outbreakHeliyon · 2021
19. Pharmacokinetic / pharmacodynamic relationships of liposomal amphotericin B and miltefosine in experimental visceral leishmaniasisPLoS neglected tropical diseases · 2021
20. COVID-19 Vaccines in Clinical Trials and their Mode of Action for Immunity against the VirusCurrent Pharmaceutical Design · 2020